Research Links Mitochondrial Dysfunction to Immune Decline, Opening Paths for Cancer Treatment
Mercola | 14 March 2024 New research shows mitochondrial dysfunction in T cells leads to immune system decline, affecting the body’s ability to fight infections and cancer The study identifies glycolysis as an inefficient way to produce energy, and the reactive oxygen species (ROS) produced in the process damage T cells The findings suggest reversing mitochondrial damage could improve immune response and cancer therapies Excess linoleic acid (LA) intake and estrogen dominance are major contributors toRead More→